Key result
Thyroidectomy under mechanical circulatory support rescues refractory thyrotoxicosis-induced cardiogenic shock.
Why the study?
Long-term amiodarone use in patients with left ventricular assist devices can cause hyperthyroidism leading to cardiomyopathy and thyrotoxicosis-induced cardiogenic shock, with limited data on salvage treatments.
Case Report (n=2)
Answers are grounded in this paper and cite their sources.
Thyroidectomy under MCS may rescue amiodarone-related thyrotoxicosis-induced CS in LVAD patients; hypothesis-generating and requires prospective validation.
Amiodarone is frequently used to treat arrhythmias in patients supported with left ventricular assist devices. Long term amiodarone use can cause hyperthyroidism ultimately leading to cardiomyopathy and sometimes thyrotoxicosis-induced cardiogenic shock (CS). We describe two cases of thyrotoxicosis-induced CS rescued by successful thyroidectomy under mechanical circulatory support (MCS) – one with a Heartmate III (Abbott Laboratories) and another supported with veno-arterial extracorporeal membrane oxygenation (V-A ECMO). In refractory CS, the initiation of V-A ECMO as a bridge to recovery is critical. In thyrotoxicosis-induced CS that is refractory to medical therapy requiring MCS, thyroidectomy is feasible, and a growing body of evidence suggests that it is safe.
No takes yet. Share an insight, caveat, or question.
Chaaya et al. (2021) conducted a case report in Thyrotoxicosis-induced cardiogenic shock (n=2). Thyroidectomy under mechanical circulatory support was evaluated on Successful rescue from cardiogenic shock. Thyroidectomy under mechanical circulatory support successfully rescued two patients with refractory thyrotoxicosis-induced cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: